Pancytopenia clinical trials
The registry lists 22 studies for Pancytopenia across 6 countries. 4 are recruiting or about to start. 5 of them are mainly about Pancytopenia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.
Get an email when these change. Save the Pancytopenia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
National Heart, Lung, and Blood Institute (NHLBI) (9) · Assiut University (3) · Novartis Pharmaceuticals (2) · Shwachman-Diamond Syndrome Alliance Inc (1) · Peter MacCallum Cancer Centre, Australia (1) · National Institute of Dental and Craniofacial Research (NIDCR) (1) · Dren Bio (1) · Medical University of Graz (1)
What is being tested here
Drugs under test in Pancytopenia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Dibotatug | 1 | 0 | 1 |
| Eltrombopag | 0 | 0 | 3 |
| Cyclosporine | 0 | 0 | 3 |
| Cyclophosphamide | 0 | 0 | 2 |
| Thymoglobulin | 0 | 0 | 2 |
| Fludarabine | 0 | 0 | 1 |
| Antilymphocyte Serum | 0 | 0 | 1 |
| Alemtuzumab | 0 | 0 | 1 |
| Ancestim | 0 | 0 | 1 |
Who these studies take
Of the 3 Pancytopenia studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (67%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (67%) | 2 (67%) |
| 18 | 3 (100%) | 3 (100%) |
| 30 | 3 (100%) | 3 (100%) |
| 40 | 3 (100%) | 3 (100%) |
| 50 | 3 (100%) | 3 (100%) |
| 65 | 3 (100%) | 3 (100%) |
| 75 | 3 (100%) | 3 (100%) |
| 85 | 3 (100%) | 3 (100%) |
Across all 22 studies, recruiting or not: 36% stop at 75 or younger and 27% at 65; 77% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting1
Studies
Recruiting first, then most recently updated. Showing 22 of 22. search them.
- A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure SyndromesRecruitingNCT07712562Phase 1/21 country
- Clinical, Hematological and Pathological Profile of PancytopeniaNot yet recruitingNCT07785726
- Shwachman-Diamond Syndrome Global Patient Survey and Partnering PlatformRecruitingNCT069999541 country
- Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)RecruitingNCT051967891 country
- Eltrombopag for Fanconi AnemiaActive, not recruitingNCT03206086Phase 21 country
- Eltrombopag With Standard Immunosuppression for Severe Aplastic AnemiaActive, not recruitingNCT01623167Phase 1/21 country
- Severe Immune Cytopenia Registry Www.Sic-reg.OrgCompletedNCT035767421 country
- Spectrum of Hematological Disorders in PediatricsStatus unknownNCT05473650
- A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic AnemiaCompletedNCT01187017Phase 1/21 country
- Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantNo longer availableNCT012000171 country
- Collection of Blood From Patients With PancytopeniaCompletedNCT000012141 country
- Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) SubjectsCompletedNCT02404025Phase 21 country
- A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic AnemiaCompletedNCT02148133Phase 21 country
- Management of Childhood PancytopeniaStatus unknownNCT03521947
- Gene Therapy for the Treatment of Fanconi's Anemia Type CCompletedNCT00001399Phase 11 country
- Three Immunosuppressive Treatment Regimens for Severe Aplastic AnemiaCompletedNCT00260689Phase 21 country
- Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic AnemiaCompletedNCT01193283Phase 1/21 country
- Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic AnaemiaStatus unknownNCT02028416Not applicable1 country
- Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALLCompletedNCT02314273Phase 41 country
- Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic DisordersCompletedNCT00000597Phase 3
- Oral Manifestations of Aplastic AnemiaCompletedNCT000063001 country
- Stem Cell Factor Medication for Aplastic AnemiaCompletedNCT00001398Phase 11 country